Journal Of Enzyme Inhibition And Medicinal Chemistry

Journal Of Enzyme Inhibition And Medicinal Chemistry

酶抑制与药物化学杂志

  • 2区 中科院分区
  • Q1 JCR分区

期刊简介

《Journal Of Enzyme Inhibition And Medicinal Chemistry》是由Informa Healthcare出版社于2002年创办的英文国际期刊(ISSN: 1475-6366,E-ISSN: 1475-6374),该期刊长期致力于生化与分子生物学领域的创新研究,主要研究方向为医学-生化与分子生物学。作为SCIE收录期刊(JCR分区 Q1,中科院 2区),本刊采用OA开放获取模式(OA占比1%),以发表生化与分子生物学领域等方向的原创性研究为核心(研究类文章占比91.79%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在195篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Journal Of Enzyme Inhibition And Medicinal Chemistry审稿周期约为 偏慢,4-8周 。该刊近年未被列入国际预警名单,年发文量约195篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 195 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学 CHEMISTRY, MEDICINAL 药物化学
2区 2区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学 CHEMISTRY, MEDICINAL 药物化学
2区 2区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:BIOCHEMISTRY & MOLECULAR BIOLOGY SCIE Q1 56 / 313

82.3%

学科:CHEMISTRY, MEDICINAL SCIE Q1 10 / 72

86.8%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:BIOCHEMISTRY & MOLECULAR BIOLOGY SCIE Q1 37 / 313

88.34%

学科:CHEMISTRY, MEDICINAL SCIE Q1 7 / 72

90.97%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:10.3 SJR:0.949 SNIP:1.223
学科类别 分区 排名 百分位
大类:Pharmacology, Toxicology and Pharmaceutics 小类:Pharmacology Q1 31 / 313

90%

大类:Pharmacology, Toxicology and Pharmaceutics 小类:Drug Discovery Q1 17 / 157

89%

期刊发文

  • Chromone-based monoamine oxidase B inhibitor with potential iron-chelating activity for the treatment of Alzheimer's disease

    Author: Zhang, Changjun; Zhang, Yujia; Lv, Yangjing; Guo, Jianan; Gao, Bianbian; Lu, Yi; Zang, Anjie; Zhu, Xi; Zhou, Tao; Xie, Yuanyuan

    Journal: JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. 2023; Vol. 38, Issue 1, pp. 100-117. DOI: 10.1080/14756366.2022.2134358

  • Binding selectivity-dependent molecular mechanism of inhibitors towards CDK2 and CDK6 investigated by multiple short molecular dynamics and free energy landscapes

    Author: Wang, Lifei; Lu, Dan; Wang, Yan; Xu, Xiaoyan; Zhong, Peihua; Yang, Zhiyong

    Journal: JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. 2023; Vol. 38, Issue 1, pp. 84-99. DOI: 10.1080/14756366.2022.2135511

  • Development of 10-Hydroxycamptothecin-crizotinib conjugate based on the synergistic effect on lung cancer cells

    Author: Liu, Zhen; Xu, Ye; Guo, Lvqian; Li, Xinran; Gao, Junling; Xie, Weiran; Zhao, Lianbo; Teng, Yuou; Li, Xuejiao; Yu, Peng

    Journal: JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. 2023; Vol. 38, Issue 1, pp. 1-11. DOI: 10.1080/14756366.2022.2132487

  • Discovery of dual tubulin-NEDDylation inhibitors with antiproliferative activity

    Author: Fu, Dong-Jun; Wang, Ting

    Journal: JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. 2023; Vol. 38, Issue 1, pp. 166-175. DOI: 10.1080/14756366.2022.2136173

  • Design, synthesis and biological evaluation of 4-aminoquinoline derivatives as receptor-interacting protein kinase 2 (RIPK2) inhibitors

    Author: Fan, Tiantian; Ji, Yinchun; Chen, Danqi; Peng, Xia; Ai, Jing; Xiong, Bing

    Journal: JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. 2023; Vol. 38, Issue 1, pp. 282-293. DOI: 10.1080/14756366.2022.2148317

  • Ligand-based discovery of coronavirus main protease inhibitors using MACAW molecular embeddings

    Author: Dong, Jie; Varbanov, Mihayl; Philippot, Stephanie; Vreken, Fanny; Zeng, Wen-Bin; Blay, Vincent

    Journal: JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. 2023; Vol. 38, Issue 1, pp. 24-35. DOI: 10.1080/14756366.2022.2132486

  • Bioactivity and mechanisms of flavonoids in decreasing insulin resistance

    Author: Zhou, Min; Konigsberg, William H.; Hao, Canhua; Pan, Yinbo; Sun, Jie; Wang, Xiaojing

    Journal: JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. 2023; Vol. 38, Issue 1, pp. -. DOI: 10.1080/14756366.2023.2199168

  • Synthesis and biological assessment of indole derivatives containing penta-heterocycles scaffold as novel anticancer agents towards A549 and K562 cells

    Author: Zhang, Guanglong; Tang, Zhenhua; Fan, Sili; Li, Chengpeng; Li, Yan; Liu, Weiqin; Long, Xuesha; Zhang, Wenjing; Zhang, Yi; Li, Zhurui; Wang, Zhenchao; Chen, Danping; Ouyang, Guiping

    Journal: JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. 2023; Vol. 38, Issue 1, pp. -. DOI: 10.1080/14756366.2022.2163393